Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Psilocybin for Major Depressive Disorder (MDD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03866174
Recruitment Status : Not yet recruiting
First Posted : March 7, 2019
Last Update Posted : May 23, 2019
Sponsor:
Collaborators:
Bracket Global
The Emmes Company, LLC
Information provided by (Responsible Party):
Usona Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : February 2021
Estimated Study Completion Date : February 2021
Publications: